BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20182588)

  • 1. Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
    Cook M; Yu XM; Chen H
    Am J Transl Res; 2010 Feb; 2(1):119-25. PubMed ID: 20182588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.
    Cook MR; Luo J; Ndiaye M; Chen H; Kunnimalaiyaan M
    Am J Surg; 2010 Mar; 199(3):315-8; discussion 318. PubMed ID: 20226902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
    Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
    Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
    Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
    Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
    Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
    Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
    Chen H; Carson-Walter EB; Baylin SB; Nelkin BD; Ball DW
    Surgery; 1996 Aug; 120(2):168-72; discussion 173. PubMed ID: 8751579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
    Chen H; Kunnimalaiyaan M; Van Gompel JJ
    Thyroid; 2005 Jun; 15(6):511-21. PubMed ID: 16029117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
    Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.
    Nakakura EK; Sriuranpong VR; Kunnimalaiyaan M; Hsiao EC; Schuebel KE; Borges MW; Jin N; Collins BJ; Nelkin BD; Chen H; Ball DW
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4350-6. PubMed ID: 15870121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
    Kunnimalaiyaan M; Ndiaye M; Chen H
    Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.
    Wang CY; Shahi P; Huang JT; Phan NN; Sun Z; Lin YC; Lai MD; Werb Z
    Mol Clin Oncol; 2017 Jan; 6(1):7-18. PubMed ID: 28123722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors.
    Truong N; Chun SM; Kim TI; Suh YA; Jang SJ
    Tumour Biol; 2017 Jun; 39(6):1010428317706225. PubMed ID: 28621224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Haymart MR; Chen H
    Transl Oncogenomics; 2007; 2():43-7. PubMed ID: 23641144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
    Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
    Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
    Furuta M; Sakakibara-Konishi J; Kikuchi H; Yokouchi H; Nishihara H; Minemura H; Harada M; Yamazaki S; Akie K; Fujita Y; Takamura K; Kojima T; Harada T; Minami Y; Watanabe N; Oizumi S; Suzuki H; Nishimura M; Dosaka-Akita H; Isobe H;
    Oncologist; 2019 Nov; 24(11):e1172-e1179. PubMed ID: 31068386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.